Roche's Webcast Replay on Gazyva in lupus nephritis presented at ASN/ACR 2019

Roche has hosted a live audio webcast and conference call on Tuesday, 12 November 2019.

Welcome
Karl Mahler, Head of Investor Relations
Roche in immunology – overview
Mark Eisner, Global Head of Product Development – Immunology, Infectious Disease & Ophthalmology
Phase II Nobility data - efficacy and safety of obinutuzumab or placebo in combination with mycophenolate mofetil in patients with Lupus Nephritis
Larry Tsai, Global Head of Rheumatology & Respiratory Development
Q&A

Please register to access the webcast

First Name

Last name

Corporate Email

Company Name

Job Role

Country

* Mandatory

Please come back 30 minutes before the webcast start date and fill in the registration form.